🚀 go-pugleaf

Dernières parutions d'articles concernant les microARNs dans le cancer
du foie:
Most recent articles on microARNs in liver cancer:




Altered microRNA Expression Patterns in Hepatoblastoma Patients.
Magrelli A, Azzalin G, Salvatore M, Viganotti M, Tosto F, Colombo T,
Devito R, Di Masi A, Antoccia A, Lorenzetti S, Maranghi F, Mantovani
A, Tanzarella C, Macino G, Taruscio D.
Transl Oncol. 2009 Aug 18;2(3):157-63.


Identification of microRNA-181 by genome-wide screening as a critical
player in EpCAM-positive hepatic cancer stem cells.
Ji J, Yamashita T, Budhu A, Forgues M, Jia HL, Li C, Deng C, Wauthier
E, Reid LM, Ye QH, Qin LX, Yang W, Wang HY, Tang ZY, Croce CM, Wang
XW.
Hepatology. 2009 Aug;50(2):472-80.


MicroRNAs involved in tumor suppressor and oncogene pathways:
implications for hepatobiliary neoplasia.
Mott JL.
Hepatology. 2009 Aug;50(2):630-7.


MiR-122/cyclin G1 interaction modulates p53 activity and affects
doxorubicin sensitivity of human hepatocarcinoma cells.
Fornari F, Gramantieri L, Giovannini C, Veronese A, Ferracin M,
Sabbioni S, Calin GA, Grazi GL, Croce CM, Tavolari S, Chieco P,
Negrini M, Bolondi L.
Cancer Res. 2009 Jul 15;69(14):5761-7.


New hope for a microRNA therapy for liver cancer.
Rossi JJ.
Cell. 2009 Jun 12;137(6):990-2.






















InTextoResearch, Baelen, Liège, Wallonie (Wallonia), Belgique
(Belgium) & Agence Wallonne d’Information Scientifique (AWIS) (Marc
Lacroix, scimedweb@mail.com)